China SXT Pharmaceuticals (SXTC) Debt Ratio (2018 - 2026)

China SXT Pharmaceuticals (SXTC) has reported Debt Ratio for 9 consecutive years, with 0.03 the latest figure, recorded in Q1 2026.

• Quarterly Debt Ratio rose 493.13% year-over-year to 0.03 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03 (up 493.13% YoY) and the FY2026 annual result came in at 0.03, up 493.13% from the prior year.
• Debt Ratio grew to 0.03 in Q1 2026 per SXTC's latest filing, from 0.0 in the prior quarter.
• Over the last five years, Debt Ratio for SXTC reached as high as 0.05 in Q3 2022 and fell as low as 0.0 in Q3 2025.
• A 5-year average of 0.02 and a median of 0.03 in 2024 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2022 — Debt Ratio slumped 95.19% — and 2026, when it surged 493.13%.
• Year by year, Debt Ratio stood at 0.05 in 2022, then sank by 85.83% to 0.01 in 2023, then surged by 242.31% to 0.03 in 2024, then tumbled by 88.84% to 0.0 in 2025, then soared by 877.01% to 0.03 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.03, 0.0, and 0.0 for Q1 2026, Q3 2025, and Q1 2025 respectively.